v3.25.2
Note 8 - Stock-based Compensation
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

8. Stock-Based Compensation

 

The Company’s Fourth Amended and Restated 2006 Stock Option and Incentive Plan allows for granting of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, performance-based restricted stock units, unrestricted stock awards, and deferred stock awards to its officers, employees, directors, and consultants. The components of stock-based compensation expense included in the consolidated statements of operations are as follows:

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2025

   

2024

   

2025

   

2024

 
   

(in thousands)

   

(in thousands)

 

Stock option awards

  $ 910     $ 732     $ 1,810     $ 1,473  

Restricted stock units

    634       573       1,320       1,134  

Performance-based restricted stock units

    400       304       860       612  
                                 

Total stock-based compensation

  $ 1,944     $ 1,609     $ 3,990     $ 3,219  

 

Stock-based compensation is included in the Company’s consolidated statements of operations as follows:

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2025

   

2024

   

2025

   

2024

 
   

(in thousands)

   

(in thousands)

 

Cost of sales

  $ 266     $ 228     $ 552     $ 439  

Sales and marketing

    349       274       725       545  

General and administrative

    1,140       943       2,316       1,908  

Research and development

    189       164       397       327  
                                 

Total stock-based compensation

  $ 1,944     $ 1,609     $ 3,990     $ 3,219  

 

During the six months ended June 30, 2025, the Company granted 741 options. The Company did not grant any options during the six months ended June 30, 2024. During the six months ended June 30, 2025 and 2024, the Company granted 1,521 and 222 restricted stock units, respectively. During the six months ended June 30, 2025, the Company granted 129 performance-based restricted stock units. The Company did not grant any performance-based restricted stock units during the six months ended June 30, 2024. The Company issued 93,658 and 147,540 shares of common stock following the exercise or vesting of underlying stock options, restricted stock units, and performance-based restricted stock units during the six months ended June 30, 2025 and 2024, respectively.